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6-Nitroso-l,2-benzopyrone. an oxidation product of 6-amino-1.2-benzopyrone. binds to the DNA-recognizing domain of the ADP-ribose trans- 
ferase protein and preferentially destabilizes Zn’+ from one of the two zinc finger polypeptide complexes preseit in the intact enzyme, as determined 
by the loss of 50% of “ZZn’” from the *‘Zn”-isolated protein molecule. coincidental with the loss of99% of enzymatic activity. The 50% zinc-deficient 
enzyme still binds to a DNA template. consisting of a l7-mer DNA primer annealed to Ml3 positive strand. resulting in the blocking of DNA 
synthesis by the Klenow fragment of Pol I. Auto-poly-ADP-ribosylated ADP-ribose transferase, which is the probable physiological state of this 
protein in intact cells, does not bind to primer-template DNA and does not block DNA synthesis by the Klenow Fragment. On the basis of this 
in vitro model it is proposed that molecules which inhibit or inactivate ADP-ribose transferase in intact cells can induce significant alteration in 
DNA structure and replication. 
Zinc finger; 6-Nitroso-l.2-bcnzopyrone: ADP-ribosc transferase 
1, INTRODUCTION 
The major cell biological action of inhibitory ligands 
of the poly(ADP-ribose) polymerase activity of ADPRT 
(ADP-ribose) transferase; EC 2.4.4.30) consists of a cell 
cycle-dependent prevention of carcinogen-induced ma- 
lignant transformation of human fibroblasts [1], confer- 
ring also carcinogen resistance 121, inhibition of mali- 
gnant transformation in hamster embryo and mouse 
C3H 1 OTl/2 cell cultures [3], deletion of transfected on- 
cogenes from NIH 3T3 cells [4], suppression of the mi- 
togenic stimulation of tumor promoters [5], inhibition 
of illegitimate DNA recombinations [6] and integration 
[7], induction of sister chromatid exchange [8] and the 
loss of certain amplified oncogenes [9,10]. The molecu- 
lar structures of inhibitory ADPRT ligands vary from 
benzamide [l], substituted benzamides [3,5,7,9,10], 3- 
aminonaphthylhydrazide [6], isoquinoline, and querce- 
*A preliminary report on this work was presented at the Paul Mandel 
International Meeting on Poly(ADP-ribosyl)ation Reactions, Quebec, 
Canada, May 30-June 3. 1991. 
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tin. to coumarin (1,2-benzopyrone) [a]. We have demon- 
strated that 1.2-benzopyrone that binds to ADPRT at 
the DNA-recognizing domain inhibits both in cell cultu- 
res and in vivo the corticosteroid-activated malignant 
cell transformation of a rat cell line containing an onco- 
gene construct [I 11. The observed apparently pleiotro- 
pit action of inhibitory ADPRT ligands is not instanta- 
neous and requires at least l-3 cell cycles [l,2,1 I], indi- 
cating either a slow progression of cellular responses or 
possibly a biochemical transformation of certain 
ADPRT ligands to active molecular species, or both. It 
is known that 1,2-benzopyrone in vivo is readily hydro- 
xylated in the 3 and 7 positions [I23 and we found that 
the 7-hydroxy- l&benzopyrone does not inhibit 
ADPRT (unpublished results) which probably explains 
the transient nature of the antineoplastic effect of 1,2- 
benzopyrone in vivo [I 11. However, substitution of an 
amino group in position 6 [13] produced G-amino-1,2- 
benzopyrone (6-ABP) whose ADPRT inhibitory action 
and antineoplastic effect in cell cultures was not tran- 
sient [14]. We have therefore further investigated the 
biochemical fate of 6-ABP and identified a novel oxida- 
tive metabolite, 6-nitroso- 1,2-benzopyrone (6-NOBP), 
formed by mixed function oxidases of liver microsomes 
in vitro. The 6-NOBP molecule still inhibited ADPR- 
polymerase activity but also inactivated ADPRT by de- 
stabilization of one zinc ion from one of the two zinc 
fingers of this protein. 
The following report deals with this mode of action 
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of 6-NOBP in vitro, while possibly in vivo consequences 
of this reaction are subject o further investigation. 
2. EXPERIMENTAL 
6-Nitro-1,Zbenzopyrone (6-N&BP) was purchased from Pfaltz & 
Bauer (Watsrbury, CT), %mercaptoethanol, NAD’, NADPH, nucle- 
otidss, sodium tungstate, hydrogen peroxide, Tris and MES buffers 
from Sigma (St. Louis, MO), Cent:icon 30 from Amicon (Beverly, 
MA), and HPLC-grade solvents and all other chemicals (reagent 
grade) from Fisher (Santa Clara, CA). [3ZP]NAD’ (250 Ci/mmoI) and 
[32P]dCTP (650 CYmmol) were obtained from ICN radiochemicals 
(Irvine, CA) and 65ZnC12 (8.24 mCi/mg) feom DupontlMEN (Wilming- 
ton, DE). M13mp18 single-stranded circular DNA, Ml3 sequencing 
IFmer primer GTTTTCCCAGTCACGAC and the KIenow frag- 
ment of DNA polymerase I were from New England Biolabs (Beverly, 
MA). 
6.ABP was prepared from 6-NOrBP [13] and labeled in the S- 
position with ‘H using methodology previously reported [ 1 I]. The 
specific activity of tritiated GABP was 19 CXmmol. 6-NOBP was 
synthesized by the oxidation of 6-ABP (4 g/40 ml H20) at 22°C by 30% 
H,O, (5 ml) with sodium tungstate (5.93 g, in 20 ml H,O) for 1.5 h 
followed by extraction of the green product into ethyl acetate, washing 
with 0.1 N HCI, and evaporation of solvent. Recrystallization from 
warm ethanol gave 1.48 g (42%) of product with a a,,,,, at 750 nm, 
characteristic of monomeric arylnitroso compounds [15]. Mass spec- 
trum = m/z (relative intensity): 175 (M’, loo), 161 (16.88), 145 (33.77), 
133 (10.38) 117 (56.09). 89 (79.71), 63 (57.13). High resolution data 
for the M’ peak (calculated for CIHSNO,): 175.0268; found: 175.0271 
(deviation = 1.1 ppm). ‘H-NMR (CDCI,, 300 MHz) S (ppm) from 
TMS: doublet (6.572 and 6.604) H-4 split by H-3; doublet (7.472 and 
7.501) H-8 split by H-7; doublet of doublets (7.86017.866 and 7.8891 
7.896) H-7 split by H-8 and finely split by H-5; doublet (7.910 and 
7.942) H-3 split by H-4; doublet (8.308 and 8.315) H-5 finely split by 
H-7. IJVlvis spectrum in ethanol, a,,,,, (6): 750 nm (46.0), 3 16 nm (8.96 
x 103), 274 nm (2.24 x 10”). Mp.: compound polymerizes above 
16O”C, blackens and melts in the range of 325-340°C. 
Electrophoretically homogeneous ADPRT was isolated from calf 
thymus by published methods 616,171, and for loading with “Zn2’ the 
enzyme (77Opg) was incubated in 500~1 of50 mM Tris-HCl (pH 8-O), 
100 mM N&l, 10 mM 2-mercaptoethanol with 45 BCi “Zn” for 120 
h at 6°C at which time the 6SZn2’ content of the protein was in 
equilibrium with the 6sZn2+ in the exchange buffer (see Fig. 3). The 
time course of Zn*’ loading of ADPRT was determined by simultane- 
ously monitoring the specific radioactivity of ADPRT-bound 65Zn2c 
chemically [18] and radiochemically. Then ADPRT solution was con- 
centrated to a protein concentration of 3 mg/ml in Centricon 30 and 
stored at -20°C in the presence of 20% glycerol. Ejection of “Zn2’ 
from 65Znz”-loaded ADPRT by 6.NOBP was assayed in 50 mM MES 
buffer (pH 6.0) containing 150 mM NaCI, 5 mM 2-mercaptoethanol 
and varying concentrations of 6-NOBP. Enzyme-bound 6SZn2’ was 
measured by a filter binding assay [19]. Enzymatic assays for ADPRT 
activity [13,16] and for DNA synthesis on a primer annealed to Ml 3 
positive strand DNA were carried out by published methods [20]. 
The biological oxidation of 6-ABP was measured by incubating for 
30 min (37OC) 10 ml of a reaction mixture composed of 0.1 mM 
[‘H]6-ABP (26.7 mCi/mmol), 50 mM Tris-HCI (pl-17.5), 5 mM MgCl,, 
0.25 mM KCI, 1 mM NADPH and 1 mg/ml of rat liver microsomes 
[21] which were isolated from Fisher male rats pretreated with Aroclor 
1254 as reported [22]. The reaction was terminated by addition of an 
equal volume of cold acetone, and the mixture extracted with four 
lo-ml volumes of ethyl acetate, which combined were dehydrated over 
anhydrous sodium sulfate and evaporated to dryness by a stream of 
nitrogen, An aliquot of the residue dissolved in acetonitrile/water (1: 1 
v/v) was analyzed by HPLC with an elution system employing three 
solvents (A = 0.05 M potassium phosphate, pH 6.0; B = same as A 
+ 30% methanol; C = 50% acetonitrile, 50% water) at a flow rate of 
1.2 ml/min using a reversed-phase ODS column by a published method 
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Fig. 1. Identification by HPLC of [‘H]6-NOBP as the main oxidation 
product of [“H]6-ABP catalyzed by rat liver microsomes, The analyt- 
ical standard 6-NOBP (solid line) was monitored by UV absorbance 
(Icft ordinate) and the enzymatic product (dashed line) by “H-radioac- 
tivity (right ordinate) with the chromatographic retention time shown 
on the abscissa. The UV spectra of the eluate peak and 6-NOBP 
standard, as measured by the diode-array detector, were identical (not 
shown). Details of the incubation system and HPLC procedure are 
given in section 2. 
[23]. Analytical standards of 6-ABP, 6-N02BP and 6-NOBP eluted at 
22.2 min, 33.5 min and 39.2 mitt, respectively. The identity of metabo- 
lites was established by their IJV spectra nd retention times which 
were identical with the authentic standards. 
3. RESULTS 
When [3HJ6-ABP was oxidized by microsomes for 30 
min, HPLC analysis identified the main I-‘nidation prod- 
uct (7% of 6-ABP) as 6-NOBP (Fig. 1?, kth 2% of 
6-ABP oxidized to 6-NO$P formed simultaneously 
(not shown). Among the oxidation products of 6-ABP 
only 6-NOBP was an ADPRT inhibitor, and in an 
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Fig. 2. The efkcts of incubation of ADPRT with 6-NOBP on the 
enzymatic activity and 6sZnZ’ content of the ADPRT protein. The 
ordinate shows the percentage changes in enzymatic activity (100% is 
231 pmol ADPR/pg protein/min) and in “Zn” content (see Fig. 3) 
following 2 h incubation of bsZn2’-loaded ADPRT [ 171 with varying 
concentration of 6-ABP (abscissa) in a system composed of 50 mM 
MES-buffer (pH 6.0). 100 mM NaCI, 0.5 mM EDTA and 5.0 mM 
2-mercaptoethanol and varying concentrations of 6-NOBP in a final 
volume of 10~1 at 25°C. A 1~1 aliquot was used for ADPRT assay 
(see section 2) and the remaining material for the radiochemical test 
for “Zd+ content of ADPRT [19]. Closed circles indicate 65Zn2+ con- 
tent, open circles ADPRT activity. (Inset) The time course of the effect 
of 0.5 mM 6.NOBP on ADPRT activity (open circles) and ‘$Zn2’ 
content (closed circles), while the open triangles indicate the protective 
effect of 0.5 mM ZnCl, on ADPWT activity in the presence of 0.5 mM 
6.ABP. The pH 6.0 was chosen for 6-NOBP induced “Zn’* ejection 
because its rate was maximal at that value but the induced 6sZn2i efflux 
from ADPRT occurs also at pH 7.0, with a rate reduced to 30%. All 
assays were done in triplicates. which agreed within 10%. 
ADPRT assay [13] with nM NAD as substrate and a 
synthetic octamer as coenzyme, 6-NOBP inhibited 
ADPRT with a Ki OF 40 PM, as compared with Ki for 
6-ABP of 28 @4, indicating that binding to ADPRT 
still occurs, In addition there was also an unexpected 
time-dependent inactivation of the poly(ADP-ribose) 
synthesizing activity of ADPRT by 6-NOBP. Incuba- 
tion of ADPRT with increasing concentrations of 6- 
NOBP (Fig. 2) for 2 h in the presence of 5 mM 2- 
mercaptoethanol at 22°C and pM 6.0 resulted in a 
precipitous decrease of enzymatic activity coinciding 
with an ejection of “SZn2+ from the 65Zn2+-loaded en- 
zyme. The presence of 2-mercaptoethanol protected 
-SH groups of ADPRT against oxidation by the ni- 
troso compound and favored a selective attack on the 
zinc finger complexes of ADPRT. Coincidental with an 
almost total loss of polymerase act,ivity nearly half of 
the Zn” content of ADPRT was ejected by the incuba- 
tion with 6-NOBP, an effect which was not altered by 
added coenzymic DNA (cf. [16]). Either 0.5 miM ZnC1, 
or CdCl, protected against inactivation by 6-NOBP 
(top curve, inset Fig. 2), but no protection was exerted 
by Fe2+, Co2+, or Mg2* (not shown). The 6-NOBP-indu- 
ted zinc loss was reversible in vitro, but reactivation, 
within the same time frame as Zn2+ ejection, required 
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Fig. 3. Exchange of externally added @Zn2’. ADPRT-bound Zn2’ as 
a function of time of incubation. ADPRT (700 yg) was incubated at 
6°C in a buffer consisting of 50 mM Tris-HCI (pl-I 8.0), 100 mM NaCI, 
IO mM 2-mercaptoethanol and 10% (v/v) glycerol to which 45 fiCi of 
“Zn2’ (I .I2 mCi/~mol) was added. The 6sZntc and Zn’+ content of 
ADPRT were determined using published radiochemical [191 and che- 
mical [1X] methods. Assays were done in duplicates with +lO% varia- 
tion. 
simultaneous incubation with added Zn2+, dithiothrei- 
to1 and DNA (results not shown). A correct interpreta- 
tion of the 6-NOBP-induced zinc ejection from preloa- 
ded ADPRT critically depends on equilibration be- 
tween externally added GsZn2+ and both enzyme-bound 
Zn’“. As shown in Fig. 3, this was indeed attained since 
both Zn2+ of the enzyme protein exchanged with “Zn’+, 
albeit with two apparently distinct rates, as determined 
by assaying the specific radioactivity of ADPRT-bound 
Zn” as a function of time of incubation with ‘jSZn2’. 
100 
0 
ADPRT, PM 
Fig. 4. Inhibition of DNA synthesis by varying concentrations of 
native ADPRT (closed circles) and 6-NOBP-treated Zn”-deficient 
ADPRT protein (open circles). The ordinate shows DNA polymerase 
activi?y as 3 of controls, assayed as [32P]dCMP incorporation (30 min) 
by the Klenow fragment of DNA polymerase I with Ml3 ssDNk 
annealed template primer as reported [20]. The 100% value for Klenow 
polymerization is 1 It pm01 of nucleotides incorporated per 30 min in 
50 ~1 reaction mix (ZS’C). Duplicates agreed within 10%. 
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5. The effects of ADPRT (open circles), auto-poly-ADP-ribosyla- 
.._ ADPRT (closed circles), and the isolated 29 kDa polypeptide 
(open triangles) on DNA synthesis on the Ml3 ssDNA annealed 
primer [20] by the Klenow enzyme. ADPRT was auto-poly_ADP- 
ribosylated by preincubation with 0.1 mM NAD’ at pH 8.0 for 10 min 
at 25°C in the presence of all components, except the Klenow enzyme 
which was added after IO min to initiate DNA synthesis, which lasted 
for 30 min. Triplicate assays agreed within 10%. 
A quantitative measure of the binding of ADPRT to 
DNA termini was obtained by determining the inhibi- 
tion of DNA synthesis on Ml 3 ssDNA annealed primer 
[20] as illustrated in Fig. 4. Untreated ADPRT inhibited 
DNA synthesis as a function of ADPWT concentration 
and at 0.5 @¶ ADPRT nearly complete inhibition oc- 
curred (ISo = 0.17 yM). Removal of one Zn2+ ion per 
molecule of ADPRT reduced the inhibitory effect of 
ADPRT (& = 0.5 PM) but did not abolish it. ADPRT 
has no direct effect on the Klenow enzyme and in this 
system inhibition is solely due to the binding of ADPRT 
to 3’ ends of DNA primers as also tested with cocnzymic 
DNA (not shown). It is of interest that ADPRT concen- 
tration in nuclei is 1 ,&l [28] therefore these in vitro 
results have biological relevance. Based on the simila- 
rity to results with site-directed mutation of zinc finger 
PI [29] 6-NOBP appears to destabilize Zn2+ preferen- 
tially from FI. A direct testing of this lconclusion will 
require a significant quantity of ADPRT mutated in FI, 
which has thus far been assayed in cell extracts only [29]. 
The oxidation of 6-ABP to 6-NOBP by microsomal 
mixed function oxidases (Fig. 1) may not be confined 
to one system since other Op- generating enzymatic 
reactions (e.g. in granulocytes) predictably can also per- 
form this oxidation, a problem which is currently stud- 
ied. In intact cells the steady-state concentration of en- 
zymatically generated 6-NOBP should be very low be- 
cause of its facile reduction to 6-ABP by GSI-I and other 
reducing systems, except at mem.brane-associated sites 
of its formation, presumably at the nuclear membrane 
where ADPRT also resides [24,25], a locus which is 
contiguous with the endoplasmic reticulum [26,27] con- 
taining oxidases. It is also possible that the cellular 
pharmacologic action of 6-ABP is probably a composite 
effect of ADPRT inhibition by 6-ABP itself to which a 
progressive inactivation of ADPRT by locally genera- 
ted 6-NOBP is superimposed. The exact nature of this 
combined effect in cellular systems is not known. On the 
other hand, on the basis of present results the conse- 
quences of ADPRT inhibition and inactivation are pre- 
dictable. Since the turnover of poly(ADP-ribose) in in- 
tact tissues is relatively slow (fYz is between 2.6 and 4 h 
in vivo; cf. [39]), a progressive removal of the DNA- 
repelling [40] poly(ADP-ribose) from ADPRT by cata- 
bolic enzymes will take place following the inhibition 
and inactivation of poly(ADP-ribose) synthesis by 
ADPRT ligands. Thus a time-dependent emergence of 
de-ADP-ribosylated ADPRT occurs, which is then 
available for binding to specific DNA structures and 
complex cellular responses may ensue [l-l 11. 
Since ADPRT in differentiated cells exists mainly in 
the auto-poly-ABP-ribosylated form [30], the effect of 
the in vitro auto-poly-ADP-ribosylated enzyme protein 
on DNA synthesis at the primer template site was also 
determined. As shown in Fig. 5 (upper curve) the auto- 
modified enzyme completely lost its inhibitory effect at 
the primer-template site. In separate experiments it was 
found that as few as 35 ADP-ribose units per molecule 
of ADPRT were sufficient to abrogate the inhibitory 
action of ADPRT on DNA synthesis (not shown). 
The most probable mechanism of the destabilization 
of Zn2’ from ADPRT by 6-NORP is the oxidation of 
cysteine ligands [29] in the zinc finger peptide, forming 
disulfide and 6-hydroxylamino-1,2-benzopyrone, simi- 
lar to the reactivity of other nitroso compounds [38]. As 
expected, other arylnitroso compounds can also de- 
stabilize Zn2+ in ADPRT, but among the molecules so 
far tested. (nitrosobenzene, 4-nitrosophenol, l-nitroso- 
2-naphthol-3,6-disulfonic acid), 6-NOBP proved to be 
the most effective, probably because of its binding affin- 
ity to ADPRT. 
The 29 kDa terminal polypeptide of ADPRT [31] 
which contains both zinc fingers [32,33] was slightly less 
than 50% as effective an inhibitor, when present in equi- 
The facile exchange of 65Zn2c with the two enzyme- 
bound ZnZe ions of ADPRT, as illustrated in Fig. 3, is 
not a universal property of all zinc finger proteins, 
which frequently require pretreatment with organomer- 
curials [34,35] for Zn*+ release. However in both cases 
cited [34,353 only one of the zinc fingers was destabilized 
byp-hydroxymercuriphenylsulfonate, similar to our ob- 
servations with 6-NOBP in ADPRT. In our experience 
184 
molar concentration with ADPRT (Fig. 5, middle 
curve), whereas the 36 kDa and 56 kDa polypeptide 
components of ADPRT [31] had no detectable inhibi- 
tory action at equimolar concentrations with the intact 
enzyme molecule (results not shown). 
4. DISCUSSION 
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p-hydroxymercuribenzoate removed both Zn2+ ions of 
ADPRT and denatured ADPRT, in contrast to 6- 
NOBP which reversibly destabilized one Zn” ion (Fig. 
2). The apparently biphasic Zn2’ exchange in ADPRT 
(Fig. 3) may suggest dissimilarity between the two zinc 
fingers. Dissimilarity of zinc fingers within the mamma- 
lian glucocorticoid receptor was earlier indicated by 
their differing NMR relaxation times [X6]. The need for 
individual assessment of zinc binding polypeptide struc- 
tures has been recently emphasized [37]. If the in vitro 
detectable relative ease of Zn2+ exchange exists in cellu- 
lar systems, ADPRT may be a biological Zn*’ sensor, 
a question which requires further studies. 
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The 29 kDa polypeptide of ADPRT by itself has 
similar but weaker template inhibitory action than 
ADPIRT (Fig. S), suggesting that the second DNA bind- 
ing polypeptide of ADPRT (36 kDa; cf. [Sl]), which bj: 
itself is not inhibitory, in the intact ADPRT molecule 
apparently reinforces the binding of the adjacent zinc 
finger domain to DNA termini. The significance of the 
second (36 kDa) DNA binding domain of ADPRT [3 I] 
has been emphasized by the recognition of a helix-turn- 
helix motif in the cDNA of ADPRT, coding for the 36 
kDa polypeptide [41]. 
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